Skip to content

Effects of acupuncture on primary insomnia: randomized controlled trial

Effects of acupuncture on primary insomnia: randomized controlled trial

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000030035
Enrollment
Unknown
Registered
2020-01-29
Start date
2020-01-30
Completion date
Unknown
Last updated
2020-02-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

primary insomnia

Interventions

Experimental group:Acupuncture treatment 1 plus Cognitive therapy
Control group:Acupuncture treatment 2 plus Cognitive therapy

Sponsors

First Affiliated Hospital,Heilongjiang University of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1) Male or female aged 18 - 65 years old. 2) Meet the diagnostic criteria for primary insomnia (sleep latency over 30 minutes, and/or the total sleep time7 points; 4) Self-rating anxietyscale(SAS) score<50 points; 5) Self-rating depression scale(SDS) score<53 points; 6) Ppatients signed the informed consent. And the process of obtaining informed consent should comply with GCP requirements.

Exclusion criteria

Exclusion criteria: 1) Pregnancy or lactation women;sleep apnea syndromecircadian disorder; patients with severe primary diseases such as serious disease of heart, brain, kidney, lung or liver; Parkinsons disease, dementia,epilepsy;patients receiving stimulator therapy such as cardiacpacemaker or vagus nerve stimulator; 2) Patients have received medication or physical therapy during the last month; 3) Any circumtances evaluated by the researcher that could prevent patients completing the research and bring risks to patiens; 4) Legally disabled (blind, deaf, mute, mentally handicapped), psychopath; 5) Patients who are suspected or have a history of alcohol or drug abuse, or those who are likely to lose the interview according to the judgment of the researcher.

Design outcomes

Primary

MeasureTime frame
PSQI;SAS;SDS;Actigraphy;

Countries

China

Contacts

Public ContactZou Wei

First Affiliated Hospital,Heilongjiang University of Chinese Medicine

kuangzou1965@163.com+86 13351980999

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026